erlotinib hydrochloride has been researched along with Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abuo-Rahma, GEA; Aly, AA; El-Shaier, YAMM; Elbastawesy, MAI; Ramadan, M | 1 |
1 other study(ies) available for erlotinib hydrochloride and Leukemia
| Article | Year |
|---|---|
Arylidenes of Quinolin-2-one scaffold as Erlotinib analogues with activities against leukemia through inhibition of EGFR TK/ STAT-3 pathways.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Drug Design; ErbB Receptors; Erlotinib Hydrochloride; Humans; Leukemia; Models, Molecular; Quinolines; Signal Transduction; STAT3 Transcription Factor | 2020 |